Forbion European Acquisition Corp. (FRBN) Shareholders Approve enGene Deal
by Marlena Haddad on 2023-10-24 at 5:43pm

Forbion European Acquisition Corp. (NASDAQ:FRBN) announced that its shareholders approved its combination with biotech firm enGene at a special meeting held earlier today.

In connection with the meeting, FEAC’s public shareholders holding 10,379,144 Class A ordinary shares elected to redeem their shares.

The parties expect to close the business combination on or about October 31, subject to the satisfaction or waiver of the conditions with respect to the deal.

Forbion originally brought about $133 million into the deal from its trust, including $20 million in Class A shares held by its sponsor, Forbion Growth, and 166,665 shares already covered by a non-redemption agreement.

The SPAC supplemented this with a $56.9 million PIPE at $10.25 per share that drew the participation of institutional and strategic investors including BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital, Northleaf Capital Partners and CTI Life Sciences.

Forbion European inked its deal with enGene earlier this year in May. Montreal-based company enGene is developing non-viral gene therapies to treat cancers and other conditions.

All other proposals on the ballot were approved by shareholders with minimal pushback.
Recent Posts
by Kristi Marvin on 2023-12-02 at 11:45am

Terms Tracker for the Week Ending December 1, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. For the most part, this was a quiet week for filings being that it followed the Thanksgiving holiday. Ideally, bankers, lawyers and teams got a...

by Marlena Haddad on 2023-12-01 at 5:39pm

Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) announced the pricing of its $60 million IPO this evening. Its units are expected to begin trading on the Nasdaq under the symbol “AFJKU” on Monday, December 4, 2023. After the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to...

by Marlena Haddad on 2023-12-01 at 4:43pm

PROOF Acquisition Corp I (NYSE: PACI) announced this afternoon that it has closed its business combination with private aviation company Volato after shareholders approved the deal at a meeting on November 28. In total, including previous shareholder votes, shareholders opted to redeem an aggregate of 99.93% of PACI’s trust, leaving it with less than $215,000...

by Marlena Haddad on 2023-12-01 at 9:34am

Adit EdTech (NYSE: ADEX) announced this morning that its shareholders have approved its business combination with bitcoin self-mining company Griid Infrastructure at a special meeting held yesterday, November 30. A total of 8,520,710 shares of common stock, representing approximately 95.7% of the outstanding shares entitled to vote, were present at the meeting, constituting a quorum...

by Nicholas Alan Clayton on 2023-12-01 at 7:49am

At the SPAC of Dawn There had been hopes that this week would take one world conflict off the board, but combat has resumed in the Middle East as other eyes are likely to be fixed on new Fed comments today. The fighting in Gaza continues to not appear to have appreciable affects on the...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved